Veeda Clinical Research acquires Heads, a European CRO
Veeda expands its reach to major geographies and adds capabilities of late-stage clinical trial execution with strong focus on…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Veeda Clinical Research
Veeda Board appoints Dr Mahesh Bhalgat as Group CEO
Prior to joining Veeda, he was the COO for Syngene International (Biocon Group Company)
Ahammune Biosciences announces first-in-human studies for new vitiligo drug in partnership with…
Ahammune’s investigational new drug for vitiligo- AB1001 has mechanism of action that targets pathways involved in triggering…
Indian CRO industry is rich and diverse
Ajay Tandon, Managing Director, Veeda Clinical Research, talks to Akanki Sharma about the potential of Indian CROs, Veeda's…
Veeda Clinical Research receives growth capital from Sabre Partners and a group of marquee HNIs
The company has raised $16 million
Veeda Clinical Research acquires stake in preclinical CRO, Bioneeds
Veeda Clinical Research has acquired a significant minority stake in Bioneeds, a preclinical CRO based in Bangalore. Veeda will…
Patient activist groups express relief over pause of Covishield trials in India
They call for more timely responses and accountability on part of both regulators and companies to ensure patient safety